{
  "type": "hyp",
  "text": "In 1991 we demonstrated using electrophoretic mobility shift assays that 3 different factors (termed B1 B2 and B3) with affinity for the KB-enhancer target sequence were specifically detected in nuclear extracts from HIV1-infected monocytes and macrophages.\n",
  "self": {
    "NER": {
      "answers": [
        "1991",
        "3",
        "B1 B2",
        "KB"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "When was the first study of the affinity of 3 different factors for KB-enhancer",
          "How many different factors were specifically detected in nuclear extracts from HIV1-infected mon",
          "What are the two groups of factors that have affinity for the KB-enhancer target",
          "What is the target sequence for the enhancer?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "we",
        "3 different factors",
        "B1 B2",
        "B3",
        "affinity",
        "the KB-enhancer target sequence",
        "nuclear extracts",
        "HIV1-infected monocytes",
        "macrophages"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was the name of the study that showed that 3 different factors with affinity for the KB",
          "How many factors were specifically detected in nuclear extracts from HIV1-infected monocyte",
          "What are the two groups of factors that have affinity for the KB-enhancer target",
          "What are the two groups of factors that have affinity for the KB-enhancer target",
          "What did the electrophoretic mobility shift assays show about the 3 different factors?",
          "What did the 3 different factors have affinity for?",
          "What was the first sample of HIV1-infected monocytes and macrophage",
          "What type of cells were tested in 1991?",
          "What is one example of a cell that has affinity for KB-enhancer?"
        ]
      }
    }
  },
  "asked": {
    "When was the first study of the affinity of 3 different factors for KB-enhancer": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "1991",
        "answerability": 0.9686135649681091,
        "ground_truth": {
          "1991": {
            "bertscore": 1.0000001192092896,
            "f1": 1.0
          }
        }
      }
    },
    "How many different factors were specifically detected in nuclear extracts from HIV1-infected mon": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "3 different factors",
        "answerability": 0.8231603503227234,
        "ground_truth": {
          "3": {
            "bertscore": 0.7307884693145752,
            "f1": 0.5
          }
        }
      }
    },
    "What are the two groups of factors that have affinity for the KB-enhancer target": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "B1 B2 and B3",
        "answerability": 0.7687901258468628,
        "ground_truth": {
          "B1 B2": {
            "bertscore": 0.8634085655212402,
            "f1": 0.6666666666666666
          },
          "B3": {
            "bertscore": 0.8257797360420227,
            "f1": 0.4
          }
        }
      }
    },
    "What is the target sequence for the enhancer?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.2343166470527649,
        "ground_truth": {
          "KB": {
            "bertscore": 0.6955735683441162,
            "f1": 0
          }
        }
      }
    },
    "What was the name of the study that showed that 3 different factors with affinity for the KB": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.18568968772888184,
        "ground_truth": {
          "we": {
            "bertscore": 0.6748355627059937,
            "f1": 0
          }
        }
      }
    },
    "How many factors were specifically detected in nuclear extracts from HIV1-infected monocyte": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "3 different factors",
        "answerability": 0.7511603832244873,
        "ground_truth": {
          "3 different factors": {
            "bertscore": 1.0000001192092896,
            "f1": 1.0
          }
        }
      }
    },
    "What did the electrophoretic mobility shift assays show about the 3 different factors?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "B1 B2 and B3",
        "answerability": 0.8375031352043152,
        "ground_truth": {
          "affinity": {
            "bertscore": 0.6912615895271301,
            "f1": 0
          }
        }
      }
    },
    "What did the 3 different factors have affinity for?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "KB-enhancer target sequence",
        "answerability": 0.982525110244751,
        "ground_truth": {
          "the KB-enhancer target sequence": {
            "bertscore": 0.9268056154251099,
            "f1": 1.0
          }
        }
      }
    },
    "What was the first sample of HIV1-infected monocytes and macrophage": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.006682395935058594,
        "ground_truth": {
          "nuclear extracts": {
            "bertscore": 0.6898642182350159,
            "f1": 0
          }
        }
      }
    },
    "What type of cells were tested in 1991?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.3939182758331299,
        "ground_truth": {
          "HIV1-infected monocytes": {
            "bertscore": 0.6454022526741028,
            "f1": 0
          }
        }
      }
    },
    "What is one example of a cell that has affinity for KB-enhancer?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.32476818561553955,
        "ground_truth": {
          "macrophages": {
            "bertscore": 0.6406633257865906,
            "f1": 0
          }
        }
      }
    }
  }
}